These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 31678380)
81. Activatable 19F MRI nanoparticle probes for the detection of reducing environments. Nakamura T; Matsushita H; Sugihara F; Yoshioka Y; Mizukami S; Kikuchi K Angew Chem Int Ed Engl; 2015 Jan; 54(3):1007-10. PubMed ID: 25413833 [TBL] [Abstract][Full Text] [Related]
82. Wang C; Adams SR; Xu H; Zhu W; Ahrens ET ACS Appl Bio Mater; 2019 Sep; 2(9):3836-3842. PubMed ID: 33981964 [TBL] [Abstract][Full Text] [Related]
83. Fluorine-19 MRI at 21.1 T: enhanced spin-lattice relaxation of perfluoro-15-crown-5-ether and sensitivity as demonstrated in ex vivo murine neuroinflammation. Waiczies S; Rosenberg JT; Kuehne A; Starke L; Delgado PR; Millward JM; Prinz C; Dos Santos Periquito J; Pohlmann A; Waiczies H; Niendorf T MAGMA; 2019 Feb; 32(1):37-49. PubMed ID: 30421250 [TBL] [Abstract][Full Text] [Related]
84. Trityl radicals in perfluorocarbon emulsions as stable, sensitive, and biocompatible oximetry probes. Dhimitruka I; Alzarie YA; Hemann C; Samouilov A; Zweier JL Bioorg Med Chem Lett; 2016 Dec; 26(23):5685-5688. PubMed ID: 27836400 [TBL] [Abstract][Full Text] [Related]
85. Multifunctional perfluorocarbon nanoemulsions for (19)F-based magnetic resonance and near-infrared optical imaging of dendritic cells. Lim YT; Noh YW; Kwon JN; Chung BH Chem Commun (Camb); 2009 Dec; (45):6952-4. PubMed ID: 19904358 [TBL] [Abstract][Full Text] [Related]
86. In vivo clearance of Staal AHJ; Becker K; Tagit O; Koen van Riessen N; Koshkina O; Veltien A; Bouvain P; Cortenbach KRG; Scheenen T; Flögel U; Temme S; Srinivas M Biomaterials; 2020 Dec; 261():120307. PubMed ID: 32927288 [TBL] [Abstract][Full Text] [Related]
87. Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytotoxicity against cancer cells. Fang JY; Hung CF; Hua SC; Hwang TL Ultrasonics; 2009 Jan; 49(1):39-46. PubMed ID: 18554679 [TBL] [Abstract][Full Text] [Related]
88. Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization and in vitro evaluation. Nesamony J; Shah IS; Kalra A; Jung R Drug Dev Ind Pharm; 2014 Sep; 40(9):1253-63. PubMed ID: 23837519 [TBL] [Abstract][Full Text] [Related]
89. Characterization of perfluorooctylbromide-based nanoemulsion particles using atomistic molecular dynamics simulations. Lee SJ; Olsen B; Schlesinger PH; Baker NA J Phys Chem B; 2010 Aug; 114(31):10086-96. PubMed ID: 20684632 [TBL] [Abstract][Full Text] [Related]
90. Nanoparticles of perfluorocarbon emulsion contribute to the reduction of methemoglobin to oxyhemoglobin. Kozlova Е; Chernysh А; Moroz V; Sergunova V; Zavialova А; Kuzovlev А Int J Pharm; 2016 Jan; 497(1-2):88-95. PubMed ID: 26626224 [TBL] [Abstract][Full Text] [Related]
91. Perfluorocarbon Enhanced Glasgow Oxygen Level Dependent (GOLD) Magnetic Resonance Metabolic Imaging Identifies the Penumbra Following Acute Ischemic Stroke. Deuchar GA; Brennan D; Holmes WM; Shaw M; Macrae IM; Santosh C Theranostics; 2018; 8(6):1706-1722. PubMed ID: 29556351 [TBL] [Abstract][Full Text] [Related]
93. Encapsulating nanoemulsions inside eLiposomes for ultrasonic drug delivery. Javadi M; Pitt WG; Belnap DM; Tsosie NH; Hartley JM Langmuir; 2012 Oct; 28(41):14720-9. PubMed ID: 22989347 [TBL] [Abstract][Full Text] [Related]
94. In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla. Caruthers SD; Neubauer AM; Hockett FD; Lamerichs R; Winter PM; Scott MJ; Gaffney PJ; Wickline SA; Lanza GM Invest Radiol; 2006 Mar; 41(3):305-12. PubMed ID: 16481914 [TBL] [Abstract][Full Text] [Related]
95. Effects of a new perfluorocarbon emulsion on human plasma and whole-blood viscosity in the presence of albumin, hydroxyethyl starch, or modified fluid gelatin: an in vitro rheologic approach. Jouan-Hureaux V; Audonnet-Blaise S; Lacatusu D; Krafft MP; Dewachter P; Cauchois G; Stoltz JF; Longrois D; Menu P Transfusion; 2006 Nov; 46(11):1892-8. PubMed ID: 17076843 [TBL] [Abstract][Full Text] [Related]
96. 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. Lanza GM; Winter PM; Neubauer AM; Caruthers SD; Hockett FD; Wickline SA Curr Top Dev Biol; 2005; 70():57-76. PubMed ID: 16338337 [TBL] [Abstract][Full Text] [Related]
97. Perfluorocarbon compound aerosols for delivery to the lung as potential 19F magnetic resonance reporters of regional pulmonary pO2. Thomas SR; Gradon L; Pratsinis SE; Pratt RG; Fotou GP; McGoron AJ; Podgorski AL; Millard RW Invest Radiol; 1997 Jan; 32(1):29-38. PubMed ID: 9007645 [TBL] [Abstract][Full Text] [Related]
98. Temperature-controlled, phase-transition ultrasound imaging-guided photothermal-chemotherapy triggered by NIR light. Li W; Hou W; Guo X; Luo L; Li Q; Zhu C; Yang J; Zhu J; Du Y; You J Theranostics; 2018; 8(11):3059-3073. PubMed ID: 29896302 [TBL] [Abstract][Full Text] [Related]
99. Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. Janjic JM; Srinivas M; Kadayakkara DK; Ahrens ET J Am Chem Soc; 2008 Mar; 130(9):2832-41. PubMed ID: 18266363 [TBL] [Abstract][Full Text] [Related]